Skip to content
Buy This GLP
← Research
Safety

Compounded semaglutide: the vial is cheap, and that is where the error happens

A poison control center reported three cases of harm from compounded semaglutide. Two were ten-fold dosing errors, and the format is the reason they were possible.

Neil Sanders5 min read

The cheapest way to buy a GLP-1 is a vial and a syringe. That is not a marketing decision so much as a manufacturing one: a prefilled pen is a device, and a device costs money to make. It is also the part of the transaction where the published evidence of harm sits. A regional poison control center reported three cases of adverse drug events after incorrect administration of compounded semaglutide obtained from compounding pharmacies and an aesthetic spa [1], and the pattern in them is worth more than the count. Set against what this market charges, it is the clearest thing a low price buys you that nobody advertises.

What happened

Two of the three patients self-administered ten-fold dosing errors. All three had notable nausea, vomiting and abdominal pain, with most symptoms lasting for days; one also reported headache, anorexia, weakness and fatigue. One sought care at a health facility and responded to an antiemetic and intravenous fluids.

Two details from the report explain the rest. One patient received a vial with syringes for self-administration and no pharmacist counseling on proper administration was provided. And one patient reported dosing in milliliters and units rather than in milligrams — three different units for one injection, on a product whose label does not force a choice between them.

Three cases is not a rate

This is a case series and it has no denominator, so it cannot say how often this happens. What it can establish is that the failure mode is real, that it produced days of symptoms and at least one health-system visit, and that its mechanism is the format rather than the molecule. Nobody has published an incidence figure for dosing errors on compounded vials, and this article is not going to imply one.

What to do about it at checkout

Three questions, and all of them are answerable before paying. Does the seller state what units the syringe is marked in, and do those match the units on the vial label? Is counseling included, and from whom? And does the plan price include the supplies at all — several sellers on this market exclude things the headline implies are included, and injection supplies are a common one.

A fourth is worth asking as a dose rises, because the arithmetic on a vial changes when the milligrams do and most sellers publish nothing about that. If a seller cannot answer which units you will be measuring in, that is a reason to look at who else is priced rather than a detail to settle later.

Price figures above are computed from this site’s own records at build time, most recently read September 2026, across 456 priced sellers. The clinical report is cited and is not this site’s own.

Frequently asked

How common are dosing errors with compounded vials?
Nobody has published a rate. This is a case series of three with no denominator, so it establishes that the failure mode exists and what causes it, not how often it occurs.
Why can a ten-fold error happen with a vial but not a pen?
A manufactured prefilled pen doses in fixed increments. A vial and syringe do not, and the report notes that syringes not intended for semaglutide create confusion between milliliters, units and milligrams.
What should I ask a seller?
What units the syringe is marked in, whether those match the vial label, whether counseling is included and from whom, and whether supplies are inside the published price.

Sources

  1. [1] Lambson JE, et al. (2023). Administration errors of compounded semaglutide reported to a poison control center-Case series Journal of the American Pharmacists Association. PMID 37392810

More in Safety